BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 11525110)

  • 1. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
    Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
    J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
    Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
    Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction].
    Ma XJ; Zhang XH; Luo M; Li CM; Shao JH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):114-7. PubMed ID: 17418019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarction.
    Olsson KA; Harnek J; Ohlin AK; Pavlidis N; Thorvinger B; Ohlin H
    Scand Cardiovasc J; 2002 Aug; 36(4):237-40. PubMed ID: 12201972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
    Furenes EB; Arnesen H; Solheim S; Grøgaard HK; Hoffmann P; Seljeflot I
    Thromb Res; 2009 Nov; 124(5):560-4. PubMed ID: 19410278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum cardiac troponin I levels after percutaneous transluminal coronary angioplasty.
    Yang Z; Jia Y; Zhang J; Cao K; Zhang F; Ma G; Ma W
    Chin Med J (Engl); 1999 Nov; 112(11):1049-51. PubMed ID: 11721471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distinctive response of coronary artery compared acute myocardial infarction with angina pectoris associated with angioplasty].
    Sato T; Sato H; Tateishi H; Uchida T; Dote K
    Kokyu To Junkan; 1990 Sep; 38(9):887-92. PubMed ID: 2236960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty.
    Shiraki T; Takamura T; Kajiyama A; Oka T; Saito D
    J Cardiol; 2004 Jul; 44(1):13-20. PubMed ID: 15334880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial.
    Fresco C; Maggioni AP; Signorini S; Merlini PA; Mocarelli P; Fabbri G; Lucci D; Tubaro M; Gattone M; Schweiger C;
    Ital Heart J; 2002 Oct; 3(10):587-92. PubMed ID: 12478816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Success and complication rates of coronary angioplasty in the unstable angina pectoris stage after myocardial infarct--a comparison with percutaneous transluminal coronary angioplasty in the acute infarct stage and unstable angina pectoris without preceding myocardial infarct].
    Haase KK; Mauser M; Voelker W; Ickrath O; Karsch KR
    Z Kardiol; 1989 Feb; 78(2):81-5. PubMed ID: 2524138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation?
    Schäfer U; Kurz T; Jain D; Hartmann F; Dendorfer A; Tölg R; Raasch W; Dominiak P; Katus H; Richardt G
    Basic Res Cardiol; 2002 Sep; 97(5):399-408. PubMed ID: 12200640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vasoreactivity to ergonovine after angioplasty: difference between the infarct-related coronary artery and the noninfarct-related coronary artery.
    Yoshitomi Y; Kojima S; Sugi T; Matsumoto Y; Yano M; Kuramochi M
    Coron Artery Dis; 1998; 9(2-3):105-11. PubMed ID: 9647411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infarction.
    Kametsu Y; Kitagawa Y; Sekiyama S; Takagi S
    Tokai J Exp Clin Med; 2005 Sep; 30(3):171-6. PubMed ID: 16285608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: implication of acute coronary events.
    Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Fuji T; Takahashi H; Iida K; Matsumoto M; Kumabe T; Sato Y; Hirayama A
    Int J Cardiol; 2009 Jun; 135(2):202-6. PubMed ID: 18614250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.